Bellus Health

Bellus Health: BELLUS Health- developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. BELLUS' lead product candidate, BLU-5937, is being developed for the treatment of chronic cough (Phase II announced July 2020) and chronic pruritus (Phase II planned to begin 1H20).

BELLUS' Phase II for chronic cough, the RELIEF study is a dose-escalation, placebo-controlled, and crossover design to assess the efficacy, safety, and tolerability of BLU-5937, a highly selective P2X3 antagonist, at four doses; 25, 50, 100 and 200 mg, administered orally, twice-daily (BID). Approximately 65 patients with refractory chronic cough are expected to be enrolled at twelve clinical sites in the United Kingdom and United States.
Based in...
North America
Clinical Stage
Phase l or ll
Disease Space
Dermatology, Respiratory
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Small Molecule
275 Armand-Frappier Boulevard
Laval, Quebec H7V 4A7

Company Participants at Solebury Trout Virtual Management Access Event - 1x1 conference calls

  • Roberto Bellini, President & CEO

Top 10 Holders of BELLUS Health Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Avidity Partners Management LP 8.68 6,797,400 23.45 13F 3/31/21
Point72 Asset Management LP 7.94 6,220,058 21.46 Stakes 12/31/20
Point72 Asset Management LP (Old) 7.40 5,800,000 20.01 13F 3/31/21
RTW Investments LP 6.34 4,968,017 17.14 13F 3/31/21
Artal Group SA 6.06 4,750,000 16.39 13F 3/31/21
Invus Public Equities Advisors LLC 6.06 4,750,000 16.39 Stakes 1/11/21
OrbiMed Advisors LLC 5.05 3,954,800 13.64 13F 3/31/21
Polar Capital Holdings Plc 4.47 3,500,000 12.08 13F 3/31/21
Boxer Capital LLC 3.80 2,975,000 10.26 13F 3/31/21
Laurion Capital Management LP 3.72 2,913,619 10.05 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.